PROGNOSIS
The mortality rate in ARDS is 50 to 80 per cent. In any particular patient this is strongly influenced by the presence of other acute or chronic disorders. The cause of death is often unclear. Infection, particularly when associated with bacteremia of unknown origin, is a major determinant of mortality. Inadequate tissue oxygenation and organ failure are also likely to play significant roles.
Of those patients who survive the acute event, the prognosis depends primarily on the presence of other underlying disease. For most patients who began with normal lungs, pulmonary function returns slowly toward normal. A small number of patients will be left with residual fibrosis, rarely of a severe nature.
- Nephritic Glomerulopathies
- PATHOPHYSIOLOGY OF ISCHEMIC HEART DISEASE
- Public health and environment
- Hypersensitivity Pneumonitis
- Diet
- Hematuria
- Conservative Management
- TREATMENT
- PLEURAL DISEASE
- Amyloidosis
- Polycystic Kidney Disease (PKD)
- NORMAL ABSORPTION
- CLINICAL MANIFESTATIONS
- CARDIAC TUMORS
- Focal Glomerular Sclerosis (FQS)
- Conjugated Hyperbilirubinemia
- Complications of Dialysis
- HEPATIC NEOPLASMS
- GLOMERULAR DISEASE
- Management
- Bartter’s Syndrome
- Texas MedicareRX
- Proteinuria
- Etiology and Pathogenesis
- Etiology and Pathogenesis
- Incidence
- ASTHMA
- History and Physical Examination
- Other Cystic Diseases
- POSTCAPILLARY PULMONARY HYPERTENSION
- Renal Venous Occlusion
- CLINICAL MANIFESTATIONS OF ENDSTAGE RENAL DISEASE
- THE FAMILIAL POLYPOSIS SYNDROMES
- Medicaid Reform Project
- Mesangioproliferative Glomerulonephritis